Evidence map›Paper›PMID 33363535›Full record

ArticleFrontiers in immunology2020

Methods to Detect MHC-Specific IgE in Mice and Men.

Anna Marianne Weijler, Jasmin Mucha, Andreas Michael Farkas, Ulrike Baranyi, Nina Pilat, Ara Cho, Moritz Muckenhuber, Stefan Hopf, Markus Wahrmann, Birgit Linhart and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Prospective assessment of pre-existing andFrontiers in immunology · 2023
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Anna Marianne WeijlerSection of Transplantation Immunology, Department of Surgery, Medical University of Vienna, Vienna, Austria.
Jasmin MuchaSection of Transplantation Immunology, Department of Surgery, Medical University of Vienna, Vienna, Austria.
Andreas Michael FarkasSection of Transplantation Immunology, Department of Surgery, Medical University of Vienna, Vienna, Austria.
Ulrike BaranyiCardiac Surgery Research Laboratory, Division of Cardiac Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria.
Nina PilatSection of Transplantation Immunology, Department of Surgery, Medical University of Vienna, Vienna, Austria.
Ara ChoSection of Transplantation Immunology, Department of Surgery, Medical University of Vienna, Vienna, Austria.
Moritz MuckenhuberSection of Transplantation Immunology, Department of Surgery, Medical University of Vienna, Vienna, Austria.
Stefan HopfSection of Transplantation Immunology, Department of Surgery, Medical University of Vienna, Vienna, Austria.
Markus WahrmannDivision of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Birgit LinhartDivision of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Rudolf ValentaDivision of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Thomas WekerleSection of Transplantation Immunology, Department of Surgery, Medical University of Vienna, Vienna, Austria.
Medical University of Vienna · ATKarl Landsteiner University of Health Sciences · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Humoral immunity is a major barrier limiting long-term outcome after organ transplantation. Especially, the production of antibodies directed against donor HLA/MHC antigens (i.e. donor-specific antibodies (DSA)) leading to antibody-mediated rejection (ABMR) is considered to be a major factor negatively affecting allograft survival. DSAs of the IgG isotype are routinely measured in transplant patients. However, not all patients diagnosed with IgG-DSA develop ABMR events. Therefore, research in better understanding the mechanisms of ABMR is of great importance. We recently demonstrated the production of MHC-specific IgE upon allograft rejection in mice and in transplant patients. IgE is classically connected with allergy and is known to be important for the humoral defense against helminths and worms. However, its role in autoimmune diseases and cancer has been reported recently as well. The concentration of IgE in blood is extremely low compared to other antibody isotypes. Therefore, detection of MHC-specific IgE from serum requires methods of high sensitivity. Since MHC-specific IgG-typically present at much higher serum levels-develops as well, high specificity is also required of IgE detection methods. In the murine model we developed an enzyme linked immunosorbent assay (ELISA) using MHC monomers for measurement of MHC-specific IgE, allowing us to distinguish between specificities of antibodies against different class I and class II antigens. For measurement of functional activity of MHC-specific IgE

Indexed as

AnimalsEnzyme-Linked Immunosorbent AssayGraft RejectionHLA AntigensHumansImmunoglobulin EIsoantibodiesMiceRatsHLA AntigensImmunoglobulin EIsoantibodiesantibody-mediated rejectiondonor specific antibodiesHLAIgEMHCtransplantation

Identifiers

PMID33363535
PMCPMC7753192
OpenAlexW3111828780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.